Cargando…
Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles
Normal micelle microemulsion method was utilized for fabrication of organically modified silica (ORMOSIL) nanoparticles. The void and dye-doped nanoparticles were synthesized in nonpolar core of two different surfactants including Aerosol OT and Tween 80. The nanoparticles were characterized using t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452043/ https://www.ncbi.nlm.nih.gov/pubmed/26069499 http://dx.doi.org/10.1007/s12645-013-0035-6 |
_version_ | 1782374239318310912 |
---|---|
author | Shirshahi, Vahid Shamsipour, Fereshteh Zarnani, Amir Hassan Verdi, Javad Saber, Reza |
author_facet | Shirshahi, Vahid Shamsipour, Fereshteh Zarnani, Amir Hassan Verdi, Javad Saber, Reza |
author_sort | Shirshahi, Vahid |
collection | PubMed |
description | Normal micelle microemulsion method was utilized for fabrication of organically modified silica (ORMOSIL) nanoparticles. The void and dye-doped nanoparticles were synthesized in nonpolar core of two different surfactants including Aerosol OT and Tween 80. The nanoparticles were characterized using transmission electron microscopy, dynamic light scattering, and zeta potential analysis. Our results revealed that the type of surfactant molecules has a dramatic impact on the size and size distribution range, surface charge, and surface functionalization of the nanoparticles. The particles fabricated using Tween 80 had very smaller size with narrow size distribution and very lower amount of zeta potential. For specific delivery of functionalized nanoparticles to breast cancer cell line SKBR3, overexpressing human epidermal growth factor receptor 2 (HER2), both dye-doped nanoparticles fabricated with Aerosol OT or Tween 80, was conjugated to Herceptin. In vitro studies using fluorescent microscopy demonstrated that the surfactant used for preparation of the nanoparticles can affect the uptake of the particles by cells. The dye-doped functionalized ORMOSIL nanoparticles prepared with Aerosol OT showed better efficiency in the process of active targeting of HER2 receptor. Herceptin-functionalized ORMOSIL nanoparticles can be used for differentiation of HER2-positive from HER2-negative breast cancer cells or specific delivery of therapeutic and diagnostic agents and also other nanoparticles such as magnetic nanoparticles and quantum dots to breast cancer cells. [Figure: see text] |
format | Online Article Text |
id | pubmed-4452043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-44520432015-06-09 Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles Shirshahi, Vahid Shamsipour, Fereshteh Zarnani, Amir Hassan Verdi, Javad Saber, Reza Cancer Nanotechnol Original Paper Normal micelle microemulsion method was utilized for fabrication of organically modified silica (ORMOSIL) nanoparticles. The void and dye-doped nanoparticles were synthesized in nonpolar core of two different surfactants including Aerosol OT and Tween 80. The nanoparticles were characterized using transmission electron microscopy, dynamic light scattering, and zeta potential analysis. Our results revealed that the type of surfactant molecules has a dramatic impact on the size and size distribution range, surface charge, and surface functionalization of the nanoparticles. The particles fabricated using Tween 80 had very smaller size with narrow size distribution and very lower amount of zeta potential. For specific delivery of functionalized nanoparticles to breast cancer cell line SKBR3, overexpressing human epidermal growth factor receptor 2 (HER2), both dye-doped nanoparticles fabricated with Aerosol OT or Tween 80, was conjugated to Herceptin. In vitro studies using fluorescent microscopy demonstrated that the surfactant used for preparation of the nanoparticles can affect the uptake of the particles by cells. The dye-doped functionalized ORMOSIL nanoparticles prepared with Aerosol OT showed better efficiency in the process of active targeting of HER2 receptor. Herceptin-functionalized ORMOSIL nanoparticles can be used for differentiation of HER2-positive from HER2-negative breast cancer cells or specific delivery of therapeutic and diagnostic agents and also other nanoparticles such as magnetic nanoparticles and quantum dots to breast cancer cells. [Figure: see text] Springer Vienna 2013-03-27 2013 /pmc/articles/PMC4452043/ /pubmed/26069499 http://dx.doi.org/10.1007/s12645-013-0035-6 Text en © Springer-Verlag Wien 2013 |
spellingShingle | Original Paper Shirshahi, Vahid Shamsipour, Fereshteh Zarnani, Amir Hassan Verdi, Javad Saber, Reza Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles |
title | Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles |
title_full | Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles |
title_fullStr | Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles |
title_full_unstemmed | Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles |
title_short | Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles |
title_sort | active targeting of her2-positive breast cancer cells by herceptin-functionalized organically modified silica nanoparticles |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452043/ https://www.ncbi.nlm.nih.gov/pubmed/26069499 http://dx.doi.org/10.1007/s12645-013-0035-6 |
work_keys_str_mv | AT shirshahivahid activetargetingofher2positivebreastcancercellsbyherceptinfunctionalizedorganicallymodifiedsilicananoparticles AT shamsipourfereshteh activetargetingofher2positivebreastcancercellsbyherceptinfunctionalizedorganicallymodifiedsilicananoparticles AT zarnaniamirhassan activetargetingofher2positivebreastcancercellsbyherceptinfunctionalizedorganicallymodifiedsilicananoparticles AT verdijavad activetargetingofher2positivebreastcancercellsbyherceptinfunctionalizedorganicallymodifiedsilicananoparticles AT saberreza activetargetingofher2positivebreastcancercellsbyherceptinfunctionalizedorganicallymodifiedsilicananoparticles |